Vitamin C: High-Dose Vitamin C Therapy PROVEN Effective
"My doctor doesn't believe in vitamins."
Reprinted with permission from Orthomolecular Medicine News Service
75 Years of Ignored Medical Evidence
(OMNS, January 5, 2010) The medical literature has virtually ignored 75 years of physician reports and laboratory and clinical studies on successful high-dose vitamin C therapy.
The Dose Makes the Difference
Effective doses are high doses, often 1,000 times more than the US Recommended Dietary Allowance (RDA) or Daily Reference Intake (DRI). It is a cornerstone of medical science that dose affects treatment outcomes. This premise is accepted with pharmaceutical drug therapy, but not with vitamin therapy. Most unsuccessful vitamin C research has used inadequate, low doses. Low doses do not get clinical results.
Consistent Excellent Results
Investigators using vitamin C in high doses have consistently reported excellent results. High doses were advocated almost immediately after ascorbic acid was isolated by Albert Szent-Gyorgyi, M.D. (1893-1986).
Medical Pioneers of High-Dose Vitamin C Therapy
Dr. Claus Washington Jungeblut
(1898-1976)
Professor of Bacteriology at Columbia University. Pioneer in vitamin C research for polio, diphtheria, and tetanus toxin inactivation.
Dr. William J. McCormick
(1880-1968)
Demonstrated how vitamin C prevents and cures kidney stones (1946) and fights cardiovascular disease (1957).
Dr. Frederick R. Klenner
(1907-1984)
Chest disease specialist who cured 41 cases of viral pneumonia with vitamin C between 1943-1947.
Dr. Robert F. Cathcart III
(1932-2007)
Used large doses of vitamin C to treat pneumonia, hepatitis, and eventually AIDS beginning in the 1960s.
Dr. Hugh D. Riordan
(1932-2005)
Successfully used large doses of intravenous vitamin C against cancer for more than three decades, beginning in 1975.
75-Year Timeline of Vitamin C Discoveries
Polio & Diphtheria Breakthrough
Dr. Jungeblut first published on vitamin C as prevention and treatment for polio. Also showed vitamin C inactivated diphtheria toxin.
Tetanus Treatment
Jungeblut demonstrated that ascorbate inactivated tetanus toxin.
Viral Pneumonia Cures
Dr. Klenner cured 41 cases of viral pneumonia with vitamin C.
Modern Applications
Dr. Cathcart treated pneumonia, hepatitis, and AIDS. Dr. Riordan began cancer treatment protocols.
The Most Unacknowledged Success in Medicine
The use of doses of tens of thousands of milligrams of vitamin C per day may be the most unacknowledged successful research in medicine.
Heard this one before? "If vitamin C was that good, doctors would tell their patients to take a lot of it." It is surprising how many physicians have done precisely that.
What's that? Your doctor still doesn't?
Essential Reading on Vitamin C Research
Vitamin C & Cancer: Discovery, Recovery, Controversy
Vitamin C: The Future Is Now
Vitamin C: The Real Story
Scientific References
Key Studies:
- 1. Jungeblut CW. Inactivation of poliomyelitis virus by crystalline vitamin C (ascorbic acid). J Exper Med 1935. 62:317-321.
- 2. Jungeblut CW, Zwemer RL. Inactivation of diphtheria toxin in vivo and in vitro by crystalline vitamin C (ascorbic acid). Proc Soc Exper Biol Med 1935; 32:1229-34.
- 3. Jungeblut CW. Inactivation of tetanus toxin by crystalline vitamin C (l-ascorbic acid). J Immunol 1937;33:203-214.
Additional Research Resources:
Jungeblut's research published in the Journal of Experimental Medicine is available for free access at:
http://www.jem.org/contents-by-date.0.shtmlNutritional Medicine is Orthomolecular Medicine
Orthomolecular medicine uses safe, effective nutritional therapy to fight illness.
Learn More
http://www.orthomolecular.orgSubscribe (Free)
Orthomolecular Medicine News ServiceEditorial Review Board
- Carolyn Dean, M.D., N.D.
- Damien Downing, M.D.
- Michael Gonzalez, D.Sc., Ph.D.
- Steve Hickey, Ph.D.
- James A. Jackson, PhD
- Bo H. Jonsson, MD, Ph.D
- Thomas Levy, M.D., J.D.
- Jorge R. Miranda-Massari, Pharm.D.
- Erik Paterson, M.D.
- Gert E. Shuitemaker, Ph.D.
Andrew W. Saul, Ph.D., Editor and contact person.
The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.